Slough, United Kingdom

Benjamin Charles De Candole



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Benjamin Charles De Candole

Introduction

Benjamin Charles De Candole, based in Slough, GB, is a notable inventor known for his contribution to the field of polymer chemistry. With a focus on developing innovative materials, De Candole has made strides in the area of comb polymers, attracting attention for his unique approach to polymerization.

Latest Patents

De Candole holds a patent for his invention related to comb polymers. The patent describes a process for producing comb polymers through a series of systematic steps. The process involves providing specific molar equivalents of monomers and an initiator compound, alongside a catalyst capable of inducing polymerization. This innovative technique aims to enhance the efficiency and effectiveness in producing comb polymers, which have various applications in diverse industries.

Career Highlights

Currently, Benjamin Charles De Candole is affiliated with UCB Pharma, S.A., where he utilizes his expertise in chemistry and innovation. His work in the company underscores his commitment to advancing pharmaceutical research and development through cutting-edge materials and processes.

Collaborations

Throughout his career, De Candole has collaborated with notable colleagues, including Timothy John Norman and Mezher Hussein Ali. These partnerships highlight the collaborative spirit in the field of innovation, where teamwork is essential for overcoming complex challenges and driving progress.

Conclusion

In conclusion, Benjamin Charles De Candole stands out as an inventive force within the polymer chemistry landscape. His patent on comb polymers represents a significant contribution to material science, showcasing his ability to innovate in a crucial area. As he continues his work at UCB Pharma, the potential for future advancements remains promising, and his collaborations with fellow innovators further enhance the scope of his contributions to the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…